Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study

NCT06839300 is registered in ClinicalTrials.gov with AO Foundation, AO Spine as lead sponsor.

NCT NCT06839300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study
Lead sponsor
AO Foundation, AO Spine
Phase
Observational
Overall status
Recruiting
Start date
February 9, 2026
Completion date
December 1, 2029
Enrollment
260 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury